Results 201 to 210 of about 526,512 (229)

Sphingosine kinase inhibitors: a review of patent literature (2006-2015)

Expert Opinion on Therapeutic Patents, 2016
Webster L Santos, Kevin R Lynch
exaly  

Protein kinase C-dependent regulation of human erythroleukemia (HEL) cell sphingosine kinase activity

Lipids and Lipid Metabolism, 1996
R M Bell, Robert M Bell
exaly  

Normal acute and chronic inflammatory responses in sphingosine kinase 1 knockout mice

FEBS Letters, 2006
Timothy Hla, Richard L. Proia, Masataka Kohno   +2 more
exaly  

The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2

FEBS Letters, 2003
Steven W Paugh, Sarah Spiegel, Suzanne E Barbour   +2 more
exaly  

SPHINGOSINE KINASE INHIBITORS

2004
SMITH CHARLES D, FRENCH KEVIN J, YUN JONG K   +2 more
openaire   +2 more sources

Sphingosine Kinase

2006
openaire   +2 more sources

The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy

Pharmacology & Therapeutics, 2019
Jinhua Wang, Xiuping Chen, De Kang
exaly  

Inhibitors of sphingosine kinase

2012
STIEBER FRANK, WIENKE DIRK
openaire   +3 more sources

Sphingosine Kinase: Biochemical and Cellular Regulation and Role in Disease

BMB Reports, 2006
Yusuf A. Hannun
exaly  

SPHINGOSINE KINASE INHIBITORS

2016
LYNCH KEVIN R, SANTOS WEBSTER L
openaire   +4 more sources